| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | episodic kinesigenic dyskinesia 1 | PRRT2* | Prrt2* | 2 models | Alliance of Genome Resources | ||
| myoclonic dystonia 11 | SGCE* | Sgce* | 2 models | Alliance of Genome Resources | |||
| neurodevelopmental disorder with involuntary movements | GNAO1* | Gnao1* | 1 model | Alliance of Genome Resources | |||
| paroxysmal nonkinesigenic dyskinesia 1 | PNKD* | Pnkd* | 2 models | Alliance of Genome Resources | |||
| torsion dystonia 1 | TOR1A* | Tor1a* | 4 models | Alliance of Genome Resources | |||
| torsion dystonia 6 | THAP1* | Thap1* | 2 models | Alliance of Genome Resources | |||
| | focal dystonia | TOR1A | Tor1a* | 1 model | Alliance of Genome Resources | ||
| generalized dystonia | CACNA1A | Cacna1a* | 2 models | Alliance of Genome Resources | |||
| movement disease | EFNB3 | Efnb3* | 1 model | Alliance of Genome Resources | |||
| Stiff-Person syndrome | TRAK1 | Trak1* | 1 model | Alliance of Genome Resources | |||
| | blepharospasm | DRD5* | Drd5 | Alliance of Genome Resources | |||
| cervical dystonia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| childhood-onset dystonia with optic atrophy and basal ganglia abnormalities | MECR* | Mecr | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| choreatic disease | NKX2-1* | Nkx2-1 | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| choreatic disease | VPS13A* | Vps13a | Alliance of Genome Resources | ||||
| choreatic disease | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| classic dopamine transporter deficiency syndrome | SLC6A3* | Slc6a3 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | DCC* | Dcc | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | DNAL4* | Dnal4 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | RAD51* | Rad51 | Alliance of Genome Resources | ||||
| congenital mirror movement disorder | NTN1* | Ntn1 | Alliance of Genome Resources | ||||
| dopa-responsive dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| dystonia | TIMM8A* | Timm8a1 | Alliance of Genome Resources | ||||
| dystonia | SPR* | Spr | Alliance of Genome Resources | ||||
| dystonia 12 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
| dystonia 12 | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
| dystonia 16 | PRKRA* | Prkra | Alliance of Genome Resources | ||||
| dystonia 22, adult-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
| dystonia 22, juvenile-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
| dystonia 24 | ANO3* | Ano3 | Alliance of Genome Resources | ||||
| dystonia 25 | GNAL* | Gnal | Alliance of Genome Resources | ||||
| dystonia 27 | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
| dystonia 28, childhood-onset | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
| dystonia 30 | VPS16* | Vps16 | Alliance of Genome Resources | ||||
| dystonia 31 | AOPEP* | Aopep | Alliance of Genome Resources | ||||
| dystonia 32 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
| dystonia 33 | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
| dystonia 35, childhood-onset | SHQ1* | Shq1 | Alliance of Genome Resources | ||||
| dystonia 37, early-onset with striatal lesions | NUP54* | Nup54 | Alliance of Genome Resources | ||||
| dystonia 9 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| early-onset dystonia and/or spastic paraplegia | ATP5MC3* | Atp5mc3 | Alliance of Genome Resources | ||||
| episodic kinesigenic dyskinesia 3 | TMEM151A* | Tmem151a | Alliance of Genome Resources | ||||
| essential tremor | HNMT* | Hnmt | Alliance of Genome Resources | ||||
| essential tremor | DRD3* | Drd3 | Alliance of Genome Resources | ||||
| essential tremor 1 | DRD3* | Drd3 | Alliance of Genome Resources | ||||
| essential tremor 4 | FUS* | Fus | Alliance of Genome Resources | ||||
| essential tremor 5 | TENM4* | Tenm4 | Alliance of Genome Resources | ||||
| essential tremor 6 | NOTCH2NLC* | ||||||
| extrapyramidal and movement disease | CYP2D6*, CYP2D7 | Cyp2d9, Cyp2d10, Cyp2d11, Cyp2d12, Cyp2d22, Cyp2d26, Cyp2d34, Cyp2d40 | Alliance of Genome Resources | ||||
| glucose transporter type 1 deficiency syndrome 2 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
| infantile parkinsonism-dystonia 2 | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
| movement disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| movement disease | DRD2* | Drd2 | Alliance of Genome Resources | ||||
| movement disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| myoclonic dystonia 26 | KCTD17* | Kctd17 | Alliance of Genome Resources | ||||
| myoclonic dystonia 34 | KCNN2* | Kcnn2 | Alliance of Genome Resources | ||||
| Parkinsonism | BDNF* | Bdnf | Alliance of Genome Resources | ||||
| Parkinsonism | GBA1* | Gba1 | Alliance of Genome Resources | ||||
| Parkinsonism | GDNF* | Gdnf | Alliance of Genome Resources | ||||
| Parkinsonism | GCH1* | Gch1 | Alliance of Genome Resources | ||||
| Parkinsonism | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| Parkinsonism | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
| Parkinsonism | PARK7* | Park7 | Alliance of Genome Resources | ||||
| Parkinsonism | MANF* | Manf | Alliance of Genome Resources | ||||
| Parkinsonism | TH* | Th | Alliance of Genome Resources | ||||
| Parkinsonism | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| Parkinsonism | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| paroxysmal nonkinesigenic dyskinesia 3 | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| progressive supranuclear palsy | MAPT* | Mapt | Alliance of Genome Resources | ||||
| sepiapterin reductase deficiency | SPR* | Spr | Alliance of Genome Resources | ||||
| Stiff-Person syndrome | HSD17B4* | Hsd17b4 | Alliance of Genome Resources | ||||
| torsion dystonia 2 | HPCA* | Hpca | Alliance of Genome Resources | ||||
| torsion dystonia 4 | TUBB4A* | Tubb4a | Alliance of Genome Resources | ||||
| X-linked dystonia-parkinsonism | TAF1*, TAF1L | Taf1 | Alliance of Genome Resources | ||||
| X-linked parkinsonism-spasticity syndrome | ATP6AP2* | Atp6ap2 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)704Ljp | 1 model | |
| paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)671Ljp | 1 model | |
| torsion dystonia 1 | Tg(CMV-TOR1A*)2Nush | 1 model | |
| torsion dystonia 1 | Tg(Eno2-TOR1A*)13Shas | 1 model | |
| torsion dystonia 1 | Tg(CMV-TOR1A*)1Nush | 1 model | |